Basophil activation test determination of CD63 combined with CD203c is not superior to CD203c alone in identifying allergic bronchopulmonary aspergillosis in cystic fibrosis

J Allergy Clin Immunol. 2016 Oct;138(4):1195-1196. doi: 10.1016/j.jaci.2016.04.002. Epub 2016 Apr 22.

Authors

Yael Gernez¹, Jeffrey Waters², Rabindra Tirouvanziam³, Leonore Herzenberg², Richard Moss⁴

Affiliations

¹ Department of Allergy and Immunology, Mount Sinai School of Medicine, New York, NY.
² Department of Genetics, Stanford University School of Medicine, Stanford, Calif.
³ Department of Pediatrics, Emory University School of Medicine, Atlanta, Ga.
⁴ Department of Pediatrics, Stanford University School of Medicine, Stanford, Calif. Electronic address: [email protected].

PMID: 27215492
DOI: 10.1016/j.jaci.2016.04.002

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't
Comment

MeSH terms

Aspergillosis, Allergic Bronchopulmonary*
Basophil Degranulation Test
Basophils*
Cystic Fibrosis
Flow Cytometry
Humans
Phosphoric Diester Hydrolases
Tetraspanin 30

Substances

CD63 protein, human
Tetraspanin 30
Phosphoric Diester Hydrolases